The proposed class-action settlement would have been fair to all sides, said Bayer.
By
5/27/2021
Health and chemical giant Bayer said it would pursue a five-point plan to mitigate its future litigation risks over Roundup herbicide, including a discussion of whether to remain in the lawn-and-garden market and a continued pursuit of settlements of lawsuits that allege the weed killer causes cancer. Bayer announced the steps on Thursday, a day after a federal judge in California rejected a Bayer proposal to settle future lawsuits involving Roundup for $2 billion.
The proposed class-action settlement would have been fair to all sides, said Bayer. “Still, we have legal and commercial options that together will achieve a similar result in mitigating future litigation risk, and we will pursue them as quickly as possible.” Bayer says Roundup is safe to use.